Dielectric barrier discharge (DBD) plasma source oral hygiene device

The integration of a DBD plasma source in an oral hygiene device addresses dental issues by generating plasma for effective disinfection and whitening, achieving significant bacterial reduction and safe operation.

WO2026240905A1PCT designated stage Publication Date: 2026-11-19COLGATE PALMOLIVE CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/023236
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-12
Filing Date
2026-04-10
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing personal care devices are inadequate in effectively addressing dental issues such as plaque buildup, gingivitis, and bacterial infections in the oral cavity, which can lead to conditions like periodontal disease and dental caries.

Method used

A dielectric barrier discharge (DBD) plasma source element is integrated into an oral hygiene device, generating plasma to treat dental and oral tissues, using a mouthpiece tray with a cavity to deliver treatment materials like hydrogen peroxide gel, ensuring safe operation and effective disinfection and whitening.

Benefits of technology

The DBD plasma source element effectively reduces bacterial loads by a factor of one million in 90 seconds and achieves tooth whitening, meeting safety standards for ozone levels and user comfort.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026023236_19112026_PF_FP_ABST
    Figure US2026023236_19112026_PF_FP_ABST
Patent Text Reader

Abstract

An oral hygiene device may comprise a dielectric barrier discharge (DBD) plasma source element. The DBD plasma source element may be configured to be energized by an electrical power source and / or to generate plasma upon being energized. The device may comprise a mouthpiece tray configured with a cavity. The cavity may be configured to receive the DBD plasma element and / or receive dentition of the device user. The device may comprise a removable application strip having at least a first side and a second side. The application strip may be configured to receive a treatment material on the first side and / or to be interposed in the mouthpiece cavity between the DBD plasma source element and the dentition of the device user. The generated plasma may advance a treatment corresponding to the treatment material the dentition of the device user and / or an oral cavity tissue of the device user.
Need to check novelty before this filing date? Find Prior Art

Description

Attorney Docket No. 926663-OO-WO-Ol-GD DIELECTRIC BARRIER DISCHARGE (DBD) PLASMA SOURCE ORAL HYGIENE DEVICECROSS-REFERENCE TO RELATED APPLICATIONS

[0001] The present application claims the benefit of priority to United States Provisional Patent Application Serial No. 63 / 804,039, filed May 12, 2025, the entirety of which is incorporated herein by reference.GOVERNMENT LICENSE RIGHTS

[0002] This invention was made with government support under DE-AC02-09CH 11466 awarded by the U.S. Department of Energy. The government has certain rights in the invention.BACKGROUND

[0003] Various personal care devices, such as a toothbrush, razor, water pick, etc., may be used to clean the one or more body parts (e.g., teeth / dentition) in an target area (e.g., oral cavity, legs, arm pits, etc.), for example by removing plaque and / or debris from the tooth / dentition surfaces. Toothbrushes can be used for numerous oral health purposes. For example, toothbrushes can be used for whitening teeth, killing bacteria within the oral cavity / mouth, detecting the presence of bacteria within the mouth, increasing blood circulation for gum therapy, and / or reducing the pain from gum inflammation.

[0004] Dental tissue issues such as, for example, periodontal disease and dental caries (e.g., tooth cavities) are often caused by certain bacterial species in the mouth that interact with proteins present in saliva to form a film, known as plaque, that coats the teeth. If such build-up progresses, the acid produced by the bacteria can attack the teeth resulting in tooth decay. The plaque also may attack the soft gum tissue of the mouth leading to gingivitis, or periodontitis, which may affect much, if not all, of the soft tissue and bone supporting the teeth.

[0005] Gingivitis is a form of gum disease that causes material irritation of the gingiva. The gingiva is a part of the oral mucosa that covers the alveolar bone and tooth root to a level just coronal to the cement-enamel junction. In other words, the gingiva is the area / section of the gum around the base of a tooth or around the teeth. Indications of gingivitis can include swollenAttorney Docket No. 926663-OO-WO-Ol-GD gums / gingiva, red gums / gingiva, bleeding gums / gingiva, receding gums / gingiva, tooth loss, and / or halitosis.BRIEF SUMMARY

[0006] One or more techniques, processes, systems, and / or devices described herein may include an oral hygiene device. The device may comprise a dielectric barrier discharge (DBD) plasma source element. The DBD plasma source element may be configured to be energized by an electrical power source. The DBD plasma source element may be configured to generate plasma upon being energized. The device may comprise a mouthpiece tray that may be configured with a cavity. The cavity may be configured to receive the DBD plasma element. The cavity may be configured to receive dentition of the device user. The cavity may be configured to receive a treatment material. The cavity may be configured to be placed into communication with the dentition of the device user. The device may be configured such that the generated plasma advances a treatment corresponding to the treatment material of the dentition of the device user and / or an oral cavity tissue of the device user.

[0007] One or more techniques, processes, systems, and / or devices described herein may include a method of applying an oral care treatment with an oral hygiene device. One or more methods may comprise disposing a treatment material into a cavity of a mouthpiece tray. The cavity may be configured to receive the treatment material and / or a dielectric barrier discharge (DBD) plasma source element. One or more methods may comprise placing the mouthpiece tray into communication with dentition of a device user. One or more methods may comprise energizing the DBD plasma source element with an electrical power source. One or more methods may comprise generating, by the DBD plasma source element, plasma upon the energizing of the DBD plasma device. One or more methods may comprise advancing, by the generated plasma, a treatment corresponding to the treatment material of at least one of: the dentition of the device user, or an oral cavity tissue of the device user.

[0008] One or more techniques, processes, systems, and / or devices described herein may include an oral hygiene device. The device may comprise a dielectric barrier discharge (DBD) plasma source element. The DBD plasma source element may be configured to be energized by an electrical power source and / or to generate plasma upon being energized. The device may comprise a mouthpiece tray configured with a cavity. The mouthpiece cavity may be configured to receive the DBD plasma element and / or to receive dentition of the device user. The device may compriseAttorney Docket No. 926663-OO-WO-Ol-GD a removable application strip having at least a first side and a second side. The application strip may be configured to receive a treatment material on the first side and / or be interposed in the mouthpiece cavity between the DBD plasma source element and the dentition of the device user. The device may be configured such that the generated plasma advances a treatment corresponding to the treatment material of the dentition of the device user and / or an oral cavity tissue of the device user.

[0009] One or more techniques, processes, systems, and / or devices described herein may include a method of applying an oral care treatment with an oral hygiene device. One or more methods may comprise placing a dielectric barrier discharge (DBD) plasma source element into a cavity of a mouthpiece tray of the device. One or more methods may comprise applying a treatment material to a first side of a removable application strip having at least the first side and a second side. One or more methods may comprise inserting the removable application strip into the cavity of the mouthpiece tray such that the second side faces a direction of the DBD plasma source element. One or more methods may comprise inserting the mouthpiece tray into an oral cavity of a device user such that the mouthpiece tray is interposed in the mouthpiece cavity between the DBD plasma source element and dentition of the device user. One or more methods may comprise energizing the DBD plasma source element with an electrical power source. One or more methods may comprise generating, by the DBD plasma source element, plasma upon the energizing of the DBD plasma device. One or more methods may comprise advancing, by the generated plasma, a treatment corresponding to the treatment material of the dentition of the device user and / or an oral cavity tissue of the device user.BRIEF DESCRIPTION OF THE DRAWINGS

[0010] The present disclosure will become more fully understood from the detailed description and the accompanying drawings, wherein:

[0011] FIG. 1A, FIG. IB, FIG. 1C, and FIG. ID illustrate an example Flexible Weave DBD being touched and folded during operation, fitting in a mouthpiece tray, an application strip used as material to apply a treatment material, and a thin strip of Weave DBD in operation.

[0012] FIG. 2A, FIG. 2B, and FIG. 2C illustrate an example Weave DBD 1 - 2” from the detector, the Weave DBD in a mouthpiece tray 1” from the detector, and 2” from the detector.

[0013] FIG. 3 is a flowchart of a method for applying an oral care treatment with an oral hygiene device.Attorney Docket No. 926663-OO-WO-Ol-GD

[0014] FIG. 4 is an example block diagram of an example hardware configuration of a device that may function as a process control device / logic controller for a dental user oral hygiene device.

[0015] FIG. 5 illustrates an example circuit diagram of a kHz resonating power source with a variable duty cycle (pulser).

[0016] FIG. 6A, FIG. 6B, and FIG. 6C illustrate example monitoring the operation and electrical characteristics of the Weave DBD source, OES setup for verifying the presence of OH radicals, and in-situ FTIR-AS measurements of the molecular composition of the gas phase.

[0017] FIG. 7A and FIG. 7B illustrate examples of typical current and voltage traces, and a corresponding Lissajous figure.

[0018] FIG. 8A and FIG. 8B illustrate example OES of the weave plasma shows an example N2 molecular band, and a region including OH* and N2* emission.

[0019] FIG. 9A, FIG. 9B and FIG. 9C illustrate example FTIR-AS spectrum of the Weave DBD under the usual operating conditions of 40.5 kHz, 3.8 kV, species concentrations in the flex and Weave DBD, and the dependence of the relative species concentrations on the energy per cycle in the discharge.

[0020] FIG. 10A and FIG. 10B illustrate example disinfection results using a Weave DBD on GFP E. coli and by a colony counting method.

[0021] The drawings represent one or more aspects of the disclosure and do not limit the scope of invention.DETAILED DESCRIPTION

[0022] The following description of the preferred embodiment(s) is merely exemplary in nature and is in no way intended to limit the invention or inventions. The description of illustrative embodiments is intended to be read in connection with the accompanying drawings, which are to be considered part of the entire written description. In the description of the exemplary embodiments disclosed herein, any reference to direction or orientation is merely intended for convenience of description and is not intended in any way to limit the scope of the present inventions. Relative terms such as “lower,” “upper,” “horizontal,” “vertical,” “above,” “below,” “up,” “down,” “left,” “right,” “top,” “bottom,” “front” and “rear” as well as derivatives thereof (e.g., “horizontally,” “downwardly.” “upwardly,” etc.) should be construed to refer to the orientation as then described or as shown in the drawing under discussion. These relative terms are for convenience of description only and do not require a particular orientation unless explicitlyAttorney Docket No. 926663-OO-WO-Ol-GD indicated as such. Terms such as “attached,” “affixed,” “connected,” “coupled,” “interconnected,” “secured” and other similar terms refer to a relationship wherein structures are secured or attached to one another either directly or indirectly through intervening structures, as well as both movable or rigid attachments or relationships, unless expressly described otherwise. The discussion herein describes and illustrates some possible non-limiting combinations of features that may exist alone or in other combinations of features. Furthermore, as used herein, the term “or” is to be interpreted as a logical operator that results in true whenever one or more of its operands are true. Furthermore, as used herein, the phrase “based on” is to be interpreted as meaning “based at least in part on,” and therefore is not limited to the interpretation “based entirely on.”

[0023] As used throughout, ranges are used as shorthand for describing each and every value that is within the range. Any value within the range can be selected as the terminus of the range. In addition, all references cited herein are hereby incorporated by reference in their entireties. In the event of a conflict in a definition in the present disclosure and that of a cited reference, the present disclosure controls.

[0024] In the following description, where block diagrams or circuits are shown and described, one of skill in the art will recognize that, for the sake of clarity, not all peripheral components or circuits are shown in the figures or described in the description. For example, common components such as memory devices and power sources may not be discussed herein, as their role would be easily understood by those of ordinary skill in the art. Further, the terms “couple” and “operably couple” can refer to a direct or indirect coupling of two components of a circuit.

[0025] Features of the present inventions may be implemented in software, hardware, firmware, or combinations thereof. The computer programs described herein are not limited to any particular embodiment, and may be implemented in an operating system, application program, foreground or background processes, driver, or any combination thereof. The computer programs may be executed on a single computer or server processor or multiple computer or server processors.

[0026] Processors described herein may be any central processing unit (CPU), microprocessor, micro-controller, computational, or programmable device or circuit configured for executing computer program instructions (e.g., code). Various processors may be embodied in computer and / or server hardware of any suitable type (e.g., desktop, laptop, notebook, tablets, cellular phones, etc.) and may include all the usual ancillary components necessary to form a functional data processing device including without limitation a bus, software and data storage such as volatile and non-volatile memory, input / output devices, graphical user interfaces (GUIs),Attorney Docket No. 926663-OO-WO-Ol-GD removable data storage, and wired and / or wireless communication interface devices including WiFi™, Bluetooth™, LAN, cellular, satellite, etc.

[0027] Computer-executable instructions or programs (e.g., software or code) and data described herein may be programmed into and tangibly embodied in a non-transitory computer-readable medium that is accessible to and retrievable by a respective processor as described herein which configures and directs the processor to perform the desired functions and processes by executing the instructions encoded in the medium. A device embodying a programmable processor configured to such non-transitory computer-executable instructions or programs may be referred to as a “programmable device”, or “device”, and multiple programmable devices in mutual communication may be referred to as a “programmable system.” It should be noted that non-transitory “computer-readable medium” as described herein may include, without limitation, any suitable volatile or non-volatile memory including random access memory (RAM) and various types thereof, read-only memory (ROM) and various types thereof, USB flash memory, and magnetic or optical data storage devices (e.g.. intemal / external hard disks, floppy discs, magnetic tape CD-ROM, DVD-ROM, optical disk, ZIP™ drive, Blu-ray disk, and others), which may be written to and / or read by a processor operably connected to the medium.

[0028] In certain scenarios, any of the subject matter disclosed herein may be embodied in the form of computer-implemented processes and apparatuses such as processor-based data processing and communication systems or computer systems for practicing those processes. The present inventions may also be embodied in the form of software or computer program code embodied in a non-transitory computer-readable storage medium, which when loaded into and executed by the data processing and communications systems or computer systems, the computer program code segments configure the processor to create specific logic circuits configured for implementing the processes.

[0029] As described herein, a Dielectric Barrier Discharge (DBD) plasma source element and / or a power source / supply can be configured into / in communication with an oral hygiene device.

[0030] In a dental hygiene device that may comprise a DBD plasma source element (Dielectric Barrier Discharge (DBD), the device may ensure safe operation, fit into a dental tray mouthpiece, be electrically energized from an electrical power supply / source, and / or may be configured for ozone safety.Attorney Docket No. 926663-OO-WO-Ol-GD

[0031] Described herein is the operation and / or gas output from a “Weave DBD” plasma source element, electrical characteristics thereof, description of Optical Emission Spectroscopy (OES), and / or Fourier Transform Infrared Absorption Spectroscopy for gas product concentrations.

[0032] The Weave DBD plasma source element as described herein may be related by subject matter to technology as described in U.S. Patent Application No. 18 / 070,958, filed on November 29, 2022, as a national stage entry of PCT Application No. PCT / US2021 / 035346, filed June 2, 2021, the entire disclosures of all of which are incorporated by reference herein, for all purposes.

[0033] The Weave DBD plasma source element as described herein may be related by subject matter to technology as described in U.S. Patent Application No. 17 / 669,622, filed on February 11, 2022, the entire disclosure of which is incorporated by reference herein, for all purposes.

[0034] The Weave DBD plasma source element as described herein may be related by subject matter to technology as described in Patent Cooperation Treaty (PCT) Application No. PCT / US2023 / 024920, filed June 9, 2023, the entire disclosure of which is incorporated by reference herein, for all purposes.

[0035] Described herein is a dental hygiene device using plasma for, at least, tooth whitening and / or oral bacteria disinfection. Laboratory tests have demonstrated the device’s ability to whiten teeth and / or to kill bacteria. The plasma device may be the Dielectric Barrier Discharge (DBD) plasma source element. The DBD plasma source element may comprise an electrode with an area of a few centimeters on a side that is biased to high voltage (e.g., 0.5 - 5 keV). The DBD plasma source element may be covered by a (e.g., relatively thin) sheet of dielectric material. On top of the dielectric material may be a metal pattern ground electrode. The metal pattern of the ground electrode can be an array of (e.g.. relatively small) holes and / or a screen mesh. The plasma forms at the junction of the metal holes and / or screen mesh of the ground electrode and / or the dielectric sheet below / around the DBD plasma source element. The DBD plasma source element may use bare wires and / or metal surfaces that rely on its radio frequency (RF) source electrical impedance, and / or its short pulses to prevent current from entering the body of a device user.

[0036] The DBD plasma source element may be called the “Weave DBD.” The DBD plasma source element may be intrinsically safe. The DBD plasma source element may be comprised of fully insulated wires. The DBD plasma source element’s wires may be covered with silicone insulation, a chemically inert material that is generally accepted for food safety. If the oral hygiene may be battery operated, a DBD plasma source element with bare wires may rely on the body for its electrical ground. FIG. 1A illustrates an example of the Weave DBD 102 that is safe to touchAttorney Docket No. 926663-OO-WO-Ol-GD and / or does not pose any electrical danger. Considering how moist and sensitive the mouth is, the high voltages of the RF pulses represent a potential hazard. FIG. 1A and FIG. IB illustrate the example that the Weave DBD 102 may be flexible and / or can be made into the size and / or shape to (e.g., easily) adapt to curved surfaces in a mouthpiece tray 104 (such as in the cavity thereof). For example, a 10 cm x 10 cm piece made from green and yellow (color not shown, among other colors) 30-gauge wire with soft silicone insulation is shown in FIG. 1A (in black and white form). When the Weave DBD 102 may be turned on and / or may be operating a blue glow (or other color) may be seen (color not shown). The operating Weave DBD 102 may be folded and / or bent by fingers while touching the lit surface. There may be no sensation felt in touching the Weave DBD 102 with the plasma on.

[0037] FIG. 1A illustrates that a Weave DBD may be touched and / or folded during operation. FIG. IB illustrates that the Weave DBD 102 may fit into an oral cavity mouthpiece tray 104 (and / or a cavity thereof). FIG. 1C illustrates that an application strip / cloth 106 (e.g., a Tyvek® piece, etc.) may be used as a material to apply a tooth whitening gel and / or a disinfectant gel 108. The gel 108 may be placed on a first side of the application strip 106 toward / in the direction of a device user’s dentition / teeth / mouth (not shown) with a second side of the application strip (e.g., a dry side) (not shown) of the application strip 106 may be placed toward / in the direction of the Weave DBD 102. FIG. ID illustrates a thin strip of Weave DBD 102 may glow blue-purple (color / glow not shown, among other colors) when in operation.

[0038] The Weave DBD 102 may be inserted into / in a mouthpiece tray 104 of a (e.g., a Colgate) tooth whitening system and / or may be operated successfully with and / or without the tooth whitening gel. The adaptability and flexibility of the Weave DBD 102 is illustrated in FIG. IB that shows a 1 cm x 9 cm piece woven to fit in a mouthpiece tray 104 and / or a cavity of the mouthpiece tray 104. The overhanging edge / cavity edge on the mouthpiece tray 104 may hold the Weave DBD 102 in place. For a tighter fit, three hooks / slots (not shown) can be built into the mouthpiece tray 104 to slide the Weave DBD 102 in and / or hold the Weave DBD 102 in place. Since the mouthpiece tray 104 itself obscures some of the Weave DBD 102 in FIG. IB, it is also shown operating outside of the mouthpiece tray 104 in FIG. ID (e.g., which could be shown with Weave DBD glowing in operation if not illustrated in black & white form). The DBD plasma source element operation may be unaffected by its placement in the mouthpiece tray 104 (and / or cavity thereof). In one or more scenarios, not shown, the Weave DBD 102 may be disposed integrally (e.g., as a component, a fixed component, or a detachable component) with theAttorney Docket No. 926663-OO-WO-Ol-GD mouthpiece tray 104, may be placed into frictional communication with the mouthpiece tray 104, and / or may be releasably / detachably connected with the mouthpiece tray 104 with one or more connecting devices / techniques suitable for use with the Weave DBD 102 and the mouthpiece tray 104.

[0039] The DBD may be operated with dilute concentrations (3%) of hydrogen peroxide that may reduce e-coli bacteria by a factor of 1 million with only a 90 second exposure, as verified in laboratory measurements. FIG. 1C shows the application strip 106 (e.g., Tyvek®) with a tooth whitening gel 108 applied to one side / a first side. The gel 108 may deliver hydrogen peroxide with no water. The removal of water reduces the thermal heating of the application strip and DBD and may work well with DBDs. The application strip 106 does not need to be made of Tyvek®. The application strip / cloth strip 106 can be preloaded with gel 108. In an oral hygiene device, the application strip 106 may be placed over the Weave DBD 102 in the mouthpiece tray 104 before the device is used, for example.

[0040] One or more electrical power supplies / sources (e.g., a kHz power source) may be configured to attach to the mouthpiece tray 104 to form a short handle 110 and / or may be battery operated.

[0041] In one or more scenarios, an electrical power supply / source may be capable of generating several kV at up to 900 MHz. Such an electrical power source may use a separate 500 VDC electrical power supply / source.

[0042] In one or more scenarios, a miniature kHz power supply / sources may be used. Three variations were tested (See Table 1) and all three were able to visibly light the Weave DBD. The brightness may be (e.g., significantly) lower for the smallest power source. IgniterlO is the smallest and may be a useful power source and its size is compatible with one or more mouthpiece tray handles. The PVM-DrivelO supply has acceptable performance but may be too large. This unit has versatile power supply capability that is not necessary and perhaps can be redesigned to significantly reduce its size.Attorney Docket No. 926663-OO-WO-Ol-GD Power source Size Input Parameters: Output Parameters Weave Battery or outlet Observations power converterIgniter 10 l”x 1.5”x 5” 12 V DC, <12 W AC 50 kHz, 2 kV, 5 Dimly lit mAGRADDRIV1 2.5”x 1.5”x 7” 12 V DC, <36 W AC 60 kHz, 7.5 kV, Brighter,10 mA completely lit PVM-DRIVE10 3”x3”xl2” 12 V DC. 10 W AC 40-60 kHz. 4 kV, Very Bright,15 mA, adjustable completely lit duty cycleTable 1: Example High frequency power supplies for the Weave DBD

[0043] The power supplies that may be used with the Weave DBD provide safe and consistent operation while generating a safe low current and kilohertz (e.g., 20 kHz - 100 kHz) frequency output. With one or more of these supplies, the Weave DBD may be safe to touch. For additional protection, some or more, or all, electrical wires in the Weave DBD may be fully insulated.

[0044] In one or more scenarios, electrically, the power supply / sources may be a power converter using a 12 V, 6 - 36 W input (e.g., depending on the model, Table 1) that can be supplied by a battery, and / or a standard UL rated wall converter. FIG. 5 illustrates an example circuit diagram 502 of a power source / supply for the oral hygiene device. FIG. 5 also illustrates an example GRADDRIV1 kHz resonating power source with a variable duty cycle (pulser). The DC power may be applied to an oscillator circuit such shown in FIG. 5, and / or another integrated circuit with the needed / useful frequency in the range of 10 - 70 kHz. The output frequency of the oscillator circuit and the duty cycle can be regulated by one or more, or separate, potentiometers. The frequency control may be useful for achieving resonant operation which may maximize the output voltage and may minimize power losses. The output from the oscillating circuit may control a fast-switching MOSFET transistor (e.g., TPX in FIG. 5), that can provide an output voltage of -100 V. The high frequency output voltage from the MOSFET is supplied to a high voltage transformer. The transformer secondary may have an inductance that cancels the load capacitance of the Weave DBD at a frequency within the 10 - 70 kHz range. For the transformers used inAttorney Docket No. 926663-OO-WO-Ol-GD experiments, the resonant frequencies were in the 40 - 50 kHz range, perhaps for example depending on the size of the Weave DBD. If useful, the output voltage can be rectified and / or multiplied using a diode / capacitor multiplier circuit.

[0045] In one or more scenarios, the high voltage high frequency signal may be provided by a secondary of an output transformer (e.g., the high voltage output of FIG. 5). The primary current may be driven through an inductor and / or switched at a desired frequency by a MOSFET transistor. At the proper switching frequency, a capacitor is resonated with the transformer primary, and the voltage is zero when switched. This mode of operation may be similar to class E amplifier operation. The drive pulses may be generated by a “555-timer” circuit with an adjustable repetition rate. This timer circuit may be turned on and off by a second timer, operating at a fixed frequency, perhaps at an adjustable duty cycle. The duty cycle may regulate the total output power. The input power may be controlled by a switch that in GRADDRIV 1 may be integrated with the duty cycle. The input power can be provided by a battery and / or a 12 V, 2 - 3 A converter. The input connection is marked. + 12V, in FIG. 5.

[0046] The Weave DBD was tested for Ozone safety using a low-level ozone detector with a resolution of 0.01 ppm. The detector sounds an alarm when ozone concentration exceeds 5 ppm which is OSHA’s defined exposure limit. For example, a 0.3 ppm level is allowable for up to 15 minutes of continued exposure. Ozone levels were measured from the Weave DBD 204 set up on a table adjacent to the ozone detector 206 (as shown in FIG. 2A). The actual configuration of the oral hygiene device was also tested: the Weave DBD 204 mounted in the mouthpiece tray 208 with dry Tyvek® cloth / application sheet 210 placed over it (as shown in FIG. 2B), and the Tyvek® cloth covered with tooth whitening gel (e.g.. 9% H2O2 gel) (not shown). The ozone concentration was measured for the Weave DBD 204 at distances of 1” and 2” from the detector (as shown in FIG. 2A). The results of ozone tests are summarized in Table 2. If the ozone level reached 5 ppm exposure limit, the time to reach the exposure limit was recorded. If the exposure limit is not reached, then the experiment continued for 1 - 2 minutes and the detector readings were recorded every 20 (s) seconds until steady state was reached, then the time to reach the steady state and the average steady state concentration were recorded (Table 2).

[0047] In FIG. 2A, the Weave DBD 204 is on the table 1 - 2” from the detector 206. In FIG. 2B, the Weave DBD (not visible) is in the mouthpiece tray 208 about 1” from the detector 206. In FIG. 2C, the Weave DBD (not visible) is in the mouthpiece tray 208 about 2” from the detector 206.Attorney Docket No. 926663-OO-WO-Ol-GD

[0048] Table 2 illustrates ozone concentrations for the ozone detector 2” from the Weave DBD with and without a Tyvek cloth covered in hydrogen peroxide tooth whitening gel. Time indicates the time it takes to reach the indicated level and achieve a steady state concentration.Experimental condition: Power, Watts Time, seconds Ozone, ppm Weave 0.65 + / - 0.1 20 < 5 ppm Weave+cloth 0.55 + / - 0.1 20 < 5 ppm Weave+cloth+gel 0.55 + / - 0.1 30 < 1 ppm Mouthpiece+weave 0.54 + / - 0.1 60 < 0.5 ppm Mouthpiece+weave+cloth 0.54 + / - 0.1 60 < 0.9 ppm Mouthpiece+weave+cloth+gel 0.53 + / - 0.1 60 < 0.4 ppmTable 2: Example Ozone Concentrations

[0049] Table 2 illustrates that the Weave DBD without any cover at a distance of 2” from the detector on the table (e.g., FIG. 2A) reached 5 ppm of ozone at the location of the detector in 20 seconds. Covering the Weave DBD with dry Tyvek® cloth / application sheet slightly reduced the average power of the Weave DBD and the ozone level reached 5 ppm in 20 (s) seconds. Another experiment / trial involved the Weave DBD on the table as in FIG. 2 A, but now hydrogen peroxide gel is applied to the outside of the Tyvek® cloth / application sheet facing up. The presence of the gel reduced the detected ozone level. The detected levels reached a stable concentration of under 1 ppm at the end of a 30 s on time.

[0050] Another experiment / trial involved the Weave DBD mounted in a mouthpiece tray (e.g., cavity thereof). In the trials without and with dry Tyvek® cloth / application sheet, the ozone levels reached saturation in 60 (s) second and remained at the indicated levels. When the Weave DBD was operated with the cloth / application sheet and the hydrogen peroxide gel, a stable concentration of < 0.4 ppm was reached in 60 (s) second and remained at this level for at least 120 (s) second. These conditions meet the OSHA regulations. Furthermore, there was no scent of ozone. Based upon the bacteria disinfection experiments described herein, significant disinfection of 1 million can be achieved in only 90 (s) seconds. This may be the exposure limit for consumer treatment.Attorney Docket No. 926663-OO-WO-Ol-GD

[0051] The reduction in ozone levels with the application of a gel may be due to the lower operating power of the device and / or it may be due to the presence of the cloth / gel combination as either absorbers and / or sources of impurities that influence ozone production. Further reduction may be possible with reduced duty cycle of the device. Thus, the Weave DBD-based oral hygiene device as described herein may be safe to operate with a tooth whitening gel for at least 2 minutes.

[0052] FIG. 6A illustrates electrical measurements for the oral hygiene device. FIG. 6B illustrates optical emission spectroscopy for the oral hygiene device. FIG. 6C illustrates Fourier Transform Infrared Absorption Spectroscopy (FTIR-AS) for the oral hygiene device.

[0053] Electrical characteristics of the Weave DBD were monitored throughout the disinfection experiments, optical measurements, and at least some or all other operational tests. The measurement circuit was designed and constructed for testing a variety of Dielectric Barrier Devices, such as shown in FIG. 2A. Testing included a safely enclosed connection between the power source and the Weave DBD or another plasma source and a connection for a HV probe (e.g., Tektronix P6015A) to measure the voltage supplied to the high voltage electrode of the plasma source. Inside the measurement box, there is a (e.g., simple) circuit that includes a measurement capacitor, Cmeas = 10 nF for measuring the transferred charge, and a Rogowski induction coil (e.g., Pearson 2877) for measuring current in the circuit. The voltage across the measurement capacitor and the reading from the Rogowski coil were also measured by an oscilloscope.

[0054] The power to the device was supplied by four alternative high-frequency, high-voltage power sources. A PVM500-1000 (e.g., Information Unlimited) was used in some or all experiments that required precise control of the input parameters such as voltage, frequency, and duty cycle of the device. Three additional power supplies were tested. The electrical characteristics in FIG. 6A were recorded for a 2.5 cm2Weave DBD used in disinfection experiments and driven by PVM500-1000. The Weave DBD was operated in parallel resonance achieved at a frequency in the range of 30 - 50 kHz, perhaps depending on the size of the Weave DBD (e.g., higher frequencies correspond to Weave DBDs of smaller areas). The voltage amplitude was adjusted to ensure that the entire surface of the Weave DBD was uniformly lit and was in the range of 2 - 4 kV for tested devices. The duty cycle was adjusted to 10 - 25% to maintain a comfortable operational temperature < 39° C and varied depending on the operating conditions and the goals for the specific experiments.Attorney Docket No. 926663-OO-WO-Ol-GD

[0055] In one or more scenarios, FIG. 6A illustrates monitoring the operation and electrical characteristics of the DBD source. FIG. 6B illustrates OES setup for verifying the presence of OH radicals and for future plasma characterization. FIG. 6C illustrates in-situ FTIR-AS measurements of the molecular composition of the gas phase. Electrical characteristics of the Weave DBD are typical for DBD discharges driven by an AC power source.

[0056] FIG. 7A illustrates a typical current and voltage traces. FIG. 7B illustrates a corresponding Lissajous figure. Here, Vmax- 3.8 kV, 40.7 kHz, 25% duty cycle, 0.1 mJ / cycle, ~ 1W. As seen in FIG. 7A, the voltage is sinusoidal during the ON portion of the cycle. The current trace has a capacitive component, the displacement current, and sharp spikes. The current spikes correspond to the micro-discharges on the surface of the wires and in small gaps between the wires and occur symmetrically during the positive and negative voltage half-cycles. The displacement current component remains < 20 mA while the discharge current spikes reach up to 200 mA but their duration is only ~10 ns. FIG. 7B shows a plot of the charge transferred by the current spikes in each cycle (e.g., measured as voltage across the measurement capacitor Cmeas in FIG. 6A) versus the applied voltage. The area enclosed by a Lissajous figure corresponds to the discharge energy in one cycle. The average energy per cycle can be multiplied by the operating frequency and the duty cycle to compute the average discharge power of the device. The average power of the Weave DBD in some or all experiments reported here ranged 0.5 - 1 W. This power may be dissipated by the discharge between the wires and is not passed to the treated person / device user or another target.

[0057] At least three properties of the Weave DBD may make it safe for consumer use. For example, the Weave DBD may be comprised of fully insulated wire, hence the device is entirely safe to touch. The high frequency of the power sources used for the Weave DBD may contribute to the safety of the device. The current (e.g., FIG. 6A) may pass entirely between the wires and not to the device user. This might not be the case of some or all DBDs.

[0058] Optical Emission Spectroscopy (OES) may be used to obtain optical emission spectra by collecting the light from the face (e.g., a lens in FIG. 6B) of the Weave DBD and passing it through a monochromator, Acton 300i (e.g., Princeton Instruments) and onto the Andor iStar ICCD (e.g., Andor Technologies). This may provide a spectrally dispersed image of the discharge which is then converted by wavelength calibration to a spectrum shown in FIG. 8 A and FIG. 8B. The spectra are dominated by the N2* emission bands, typical for DBD in air. Shown in FIG. 8A, is a typical nitrogen emission band from the N22ndpositive system that was used to determine the gasAttorney Docket No. 926663-OO-WO-Ol-GD temperature and plasma parameters in the discharge. The optical emission spectra provide information only about the excited species in the discharge that emit light as they relax to lower energy levels. The spectra can be used to indicate the presence (although not the concentration) of the important reactive oxygen and nitrogen species important for the biological action of the device. For example, the spectrum shown in FIG. 8B shows the OH’ radical 309 nm emission band (305 - 310 nm) thus confirming the presence of the OH’ important because it is a very strong oxidizer and also initiates the production of long-lived reactive oxygen species such as H2O2. In addition to qualitative assessment of reactive species produced in plasma, OES can be used to correlate plasma characteristics to the desired operational regimes and hence to deepen the understanding of plasma applications.

[0059] FIG. 8A and FIG. 8B illustrates OES of the Weave plasma (taken face-on using Acton 300i and Andor iStar ICCD) that shows an example N2 molecular band (FIG. 8A) and region including OH* and N2* emission (FIG. 8B).

[0060] Gas composition may be analyzed using FTIR-AS. The treatment by Weave-DBD and flex-DBD exposes the surface to the plasma active species, hence, the information about the gas composition is useful to understand the mechanisms of virus inactivation and / or to optimize the treatment for different biological species. Optical emission spectroscopy confirmed the presence of the excited OH’ radical, a short-lived plasma generated species. To test the molecular composition of the plasma effluent the capability of the Fourier Transform Infrared Spectrometer (FTIR) may be expanded to be able to test the gas region close to the Weave DBD with the plasma on (FIG. 2C). The Weave DBD was placed in the FTIR short-path (10 cm) gas cell with KBr windows with an influx of ambient air. The FTIR light beam passed within 1 mm from the surface of the Weave DBD so the concentrations were determined at the conditions similar to the real-life applications of the Weave DBD and to the bio- decontamination tests conducted previously.

[0061] The measured spectra indicated in blue as FTIR data (FIG. 9 A) can be compared to the data base of molecular absorption data such as HATRAN molecular database. As shown in FIG.9A, the spectra show the presence of ozone and nitrogen oxides. The concentrations are determined by fitting the FTIR measured spectrum with the synthetic spectrum from the HATRAN database (FIG. 9A) and using the database for the absorption coefficients. This allows a determination of the absolute concentrations of main molecular species in the gas output from the device. FTIR absorption spectroscopy cannot detect the concentrations of diatomic homonuclear molecules because they are not active in IR range (dipole radiation).Attorney Docket No. 926663-OO-WO-Ol-GD

[0062] The in situ FTIR-AS method shown in FIG. 2C was used to find the gas composition of the Weave DBD as well as the Flex-DBD as a function of applied power. It was shown that flex-DBD produces a higher concentration of Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) per watt of discharge power than the Weave-DBD in their current configurations (FIG. 9B). In addition, it was shown that the ROS / RNS concentrations depend on the power of the device, and increasing the power increases the overall production of the reactive species and increasing the relative concentration of RNS compared to ROS (FIG. 9C).

[0063] In FIG. 9 A, FIG. 9B, and FIG. 9C, it may be seen that ozone production could be beneficial to maintaining an OH-concentration in the liquid solution of hydrogen peroxide. It may be a relatively primary reason for the dramatic increase in the effectiveness of hydrogen peroxide when it is combined with plasma treatment. FTIR-AS provides the concentrations of the Reactive Species in the gas output of the Weave DBD, information that may be useful for the optimization of the device performance for specific applications.

[0064] FIG. 9A illustrates FTIR-AS spectrum of the Weave DBD under the usual operating conditions of 40.5 kHz, 3.8 kV. The inset shows spectral fitting of the ozone absorption band to determine the absolute concentration of ozone. The number of scans was 128 per spectrum at 1cm- 1 spectral resolution. FIG. 9B illustrates species concentrations in the flex and Weave DBD. FIG. 9C illustrates the dependence of the relative species concentrations on the energy per cycle in the discharge.

[0065] Disinfection effectiveness has been previously conducted using GFP modified E. coli strain. Luria broth containing a high concentration of E. coli was spread on an agar plate and subjected to plasma treatment by the Weave DBD positioned at 1 mm from the surface of the agar and centered over the petri dish. Treated and untreated petri dishes were incubated at 37 °C for 24 hours and examined under the UV light. The images of the plates are seen in FIG. 10 A. The images show a uniform layer of bacteria on the control plate (0s- treatment) and only a few individual colonies left after 30 s. The treatment inactivated the bacteria over an area far exceeding the outlined area of the Weave DBD. The area of the Weave DBD is shown as a dashed square while the inactivated region seen as a lack of green glow (rendered in black & white form) extends over the area of the entire dish.

[0066] Quantitative disinfection studies were conducted following the EPA standard procedure for surface decontamination. Coupons of glass (microscope coverslips) were inoculated with E. coli and treated with plasma. The treated, untreated, and negative control coupons were washedAttorney Docket No. 926663-OO-WO-Ol-GD in Luria broth and the resulting bacterial suspension was plated in a serial dilution and incubated for 24 hours at 37 °C. Colony counts were used to quantify the disinfection efficiency (FIG. 10B). Weave DBD achieved > 5 log 10 reduction in the bacterial load of E. coli K-12 in 60 sec (FIG. 10B) and improved the action of hydrogen peroxide by > 31ogl0. Using hydrogen peroxide in conjunction with plasma treatment resulted in complete inactivation of the inoculated bacteria on a fast time scale (<30 s) making a more detailed study difficult.

[0067] FIG. 10A and FIG. 10B illustrate disinfection results using Weave DBD on GFP E. coli (FIG. 10A) and by colony counting method (FIG. 10B).

[0068] FIG. 4 is a block diagram of an example hardware configuration of an example device that may function as a process control device / logic controller, such as a dental user oral hygiene device, a dental study oral hygiene device, and / or a machine-learning algorithm processing device, among other devices. The hardware configuration 400 may be operable to facilitate delivery of information from an internal server of a device. The hardware configuration 400 can include a processor 410. a memory 420, a storage device 430. and / or an input / output device 440. One or more of the components 410, 420, 430, and 440 can, for example, be interconnected using a system bus 450. The processor 410 can process instructions for execution within the hardware configuration 400. The processor 410 can be a single-threaded processor or the processor 410 can be a multi-threaded processor. The processor 410 can be capable of processing instructions stored in the memory 420 and / or on the storage device 430.

[0069] The memory 420 can store information within the hardware configuration 400. The memory 420 can be a computer- readable medium (CRM), for example, a non-transitory CRM. The memory 420 can be a volatile memory unit, and / or can be a non-volatile memory unit.

[0070] The storage device 430 can be capable of providing mass storage for the hardware configuration 400. The storage device 430 can be a computer-readable medium (CRM), for example, a non-transitory CRM. The storage device 430 can, for example, include a hard disk device, an optical disk device, flash memory and / or some other large capacity storage device. The storage device 430 can be a device external to the hardware configuration 400.

[0071] The input / output device 440 may provide input / output operations for the hardware configuration 400. The input / output device 440 (e.g., a transceiver device) can include one or more of a network interface device (e.g., an Ethernet card), a serial communication device (e.g., an RS-232 port), one or more universal serial bus (USB) interfaces (e.g., a USB 2.0 port) and / or a wireless interface device (e.g., an 802.11 card). The input / output device can include driver devicesAttorney Docket No. 926663-OO-WO-Ol-GD configured to send communications to, and / or receive communications from one or more networks (not shown). The input / output device 400 may be in communication with one or more input / output modules (not shown) that may be proximate to the hardware configuration 400 and / or may be remote from the hardware configuration 400. The one or more output modules may provide input / output functionality in the digital signal form, discrete signal form, TTL form, analog signal form, serial communication protocol, fieldbus protocol communication and / or other open or proprietary communication protocol, and / or the like.

[0072] The camera device 460 may provide digital video input / output capability for the hardware configuration 400. The camera device 460 may communicate with any of the elements of the hardware configuration 400, perhaps for example via system bus 450. The camera device 460 may capture digital images and / or may scan images / light of various kinds, such as Universal Product Code (UPC) codes and / or Quick Response (QR) codes, reflected light from a target area, e.g., oral cavity, legs, arm pits, etc.,, and / or excited fluorescence light from a target area, e.g., oral cavity, legs, arm pits, etc., for example, among other images / light as described herein. In one or more scenarios, the camera device 460 may be the same and / or substantially similar to any of the other camera devices as may be described herein.

[0073] The camera device 460 may include at least one microphone device and / or at least one speaker device (not shown). The input / output of the camera device 460 may include audio signals / packets / components, perhaps for example separate / separable from, or in some (e.g., separable) combination with, the video signals / packets / components the camera device 460.

[0074] The camera device 460 may be in wired and / or wireless communication with the hardware configuration 400. In one or more scenarios, the camera device 460 may be external to the hardware configuration 400. In one or more scenarios, the camera device 460 may be internal to the hardware configuration 400.

[0075] FIG. 3 is a flowchart of an example technique 300 for applying an oral care treatment with an oral hygiene device. At 302, one or more techniques may start. At 304, one or more techniques may comprise disposing a treatment material into a cavity of a mouthpiece tray. The cavity may be configured to receive the treatment material and / or a dielectric barrier discharge (DBD) plasma source element. At 306, one or more techniques may comprise placing the mouthpiece tray into communication with dentition of a device user. At 308, one or more techniques may comprise energizing the DBD plasma source element with an electrical power source. At 310, one or more techniques may comprise generating, by the DBD plasma source element, plasma upon theAttorney Docket No. 926663-OO-WO-Ol-GD energizing of the DBD plasma device. At 312, one or more techniques may comprise advancing, by the generated plasma, a treatment corresponding to the treatment material of at least one of: the dentition of the device user, or an oral cavity tissue of the device user. At 314, one or more techniques may stop and / or restart.

[0076] In view of the descriptions provided herein, and in view of FIG. 1 to FIG. 10, the present disclosure describes one or more techniques, processes, systems, and / or devices. In one or more scenarios, an oral hygiene device may comprise a dielectric barrier discharge (DBD) plasma source element. The DBD plasma source element may be configured to be energized by an electrical power source. The DBD plasma source element may be configured to generate plasma upon being energized. The device may comprise a mouthpiece tray that may be configured with a cavity. The cavity may be configured to receive the DBD plasma element. The cavity may be configured to receive dentition of the device user. The cavity may be configured to receive a treatment material. The cavity may be configured to be placed into communication with the dentition of the device user. The device may be configured such that the generated plasma advances a treatment corresponding to the treatment material of at least one of: the dentition of the device user, or an oral cavity tissue of the device user.

[0077] In one or more scenarios, the mouthpiece tray may be configured to receive an application strip having at least a first side and a second side. The application strip may be configured to receive the treatment material on the first side. The application strip may be configured to be interposed in the mouthpiece cavity between the DBD plasma source element and the dentition of the device user.

[0078] In one or more scenarios, the mouthpiece tray may be configured to comprise the DBD plasma element in at least one of: a fixed connection, or a removable connection.

[0079] In one or more scenarios, the mouthpiece tray is further configured to comprise the application strip in at least one of: a fixed connection, or a removable connection.

[0080] In one or more scenarios, the (DBD) plasma source element may be a Weave DBD plasma source element. In one or more scenarios, the Weave DBD plasma source element may be configured to be flexibly adjustable in at least shape by a manual manipulation of the device user.

[0081] In one or more scenarios, the first side may be configured to face a direction of the dentition of the device user and / or the second side may be configured to face a direction of the DBD plasma source element.Attorney Docket No. 926663-OO-WO-Ol-GD

[0082] In one or more scenarios, the device may be further configured such that the treatment is a whitening of the dentition of the device user and / or a bacterial disinfection of the oral cavity tissue of the device user.

[0083] In one or more scenarios, the DBD plasma source element may be comprised of fully insulated wires. In one or more scenarios, the application strip may be composed, at least in part, of Tyvek®.

[0084] In one or more scenarios, the treatment material may be a whitening gel and / or a hydrogen peroxide gel.

[0085] In one or more scenarios, the application strip may be configured to insulate the oral cavity tissue of the device user from the generated plasma of the DBD plasma source element.

[0086] In one or more scenarios, the electrical power source may be configured to produce an alternating current output in the range of 20 kHz to 100 kHz. In one or more scenarios, the device may be further configured to limit ozone produced by the generated plasma to less than 0.4 ppm for at least 60 seconds.

[0087] In one or more scenarios, one or more methods of applying an oral care treatment with an oral hygiene device may be implemented. One or more methods may comprise disposing a treatment material into a cavity of a mouthpiece tray. The cavity may be configured to receive at least one of: the treatment material, or a dielectric barrier discharge (DBD) plasma source element. One or more methods may comprise placing the mouthpiece tray into communication with dentition of a device user. One or more methods may comprise energizing the DBD plasma source element with an electrical power source. One or more methods may comprise generating, by the DBD plasma source element, plasma upon the energizing of the DBD plasma device. One or more methods may comprise advancing, by the generated plasma, a treatment corresponding to the treatment material of at least one of: the dentition of the device user, or an oral cavity tissue of the device user.

[0088] In one or more scenarios, the cavity may be configured to receive an application strip having at least a first side and a second side. One or more methods may comprise disposing the treatment material on the first side of the application strip. One or more methods may comprise disposing the application strip into the cavity of the mouthpiece tray such that the second side faces a direction of the DBD plasma source element. In one or more scenarios, the placing the mouthpiece tray into communication with the dentition of the device user may compriseAttorney Docket No. 926663-OO-WO-Ol-GD interposing the application strip in the mouthpiece cavity between the DBD plasma source element and the dentition of the device user.

[0089] In one or more scenarios, the mouthpiece tray may be configured to comprise the DBD plasma element in at least one of: a fixed connection, or a removable connection.

[0090] In one or more scenarios, the mouthpiece tray may be configured to comprise the application strip in at least one of: a fixed connection, or a removable connection.

[0091] In one or more scenarios, the (DBD) plasma source element may be a Weave DBD plasma source element. In one or more scenarios, one or more methods may comprise flexibly adjusting at least a shape of the Weave DBD plasma source element by a manual manipulation of the device user.

[0092] In one or more scenarios, the first side may be configured to face a direction of the dentition of the device user and the second side may be configured to face a direction of the DBD plasma source element.

[0093] In one or more scenarios, the device may be further configured such that the treatment is a whitening of the dentition of the device user and / or a bacterial disinfection of the oral cavity tissue of the device user.

[0094] In one or more scenarios, the DBD plasma source element may be comprised of fully insulated wires. In one or more scenarios, the application strip may be composed, at least in part, of Tyvek®.

[0095] In one or more scenarios, the treatment material may be a whitening gel and / or a hydrogen peroxide gel.

[0096] In one or more scenarios, one or more methods may further comprise insulating, by the application strip, the oral cavity tissue of the device user from the generated plasma of the DBD plasma source element.

[0097] In one or more scenarios, the electrical power source may be configured to produce an alternating current output in the range of 20 kHz to 100 kHz.

[0098] In one or more scenarios, the device may be further configured to limit ozone produced by the generated plasma to less than 0.4 ppm for at least 60 seconds.

[0099] While the inventions have been described with respect to specific examples including presently preferred modes of carrying out the inventions, those skilled in the art will appreciate that there are numerous variations and permutations of the herein described systems and techniques. It is to be understood that other embodiments may be utilized and structural andAttorney Docket No. 926663-OO-WO-Ol-GD functional modifications may be made without departing from the scope of the present inventions. Thus, the spirit and scope of the inventions should be construed broadly as set forth in the appended claims.

[0100] The subject matter of this disclosure, and components thereof, can be realized by instructions that upon execution cause one or more processing devices to carry out the processes and / or functions described herein. Such instructions can, for example, comprise interpreted instructions, such as script instructions, e.g., JavaScript or ECMAScript instructions, or executable code, and / or other instructions stored in a computer readable medium. C ++, C#, and / or C. Python scripts and / or Zephyr RTOS may be used.

[0101] Implementations of the subject matter and / or the functional operations described in this specification and / or the accompanying figures can be provided in digital electronic circuitry, in computer software, firmware, and / or hardware, including the structures disclosed in this specification and their structural equivalents, and / or in combinations of one or more of them. The subject matter described in this specification can be implemented as one or more computer program products, e.g., one or more modules of computer program instructions encoded on a tangible program carrier for execution by, and / or to control the operation of, data processing apparatus.

[0102] A computer program (also known as a program, software, software application, script, or code) can be written in any form of programming language, including compiled or interpreted languages, and / or declarative or procedural languages. It can be deployed in any form, including as a stand-alone program or as a module, component, subroutine, and / or other unit suitable for use in a computing environment. A computer program may or might not correspond to a file in a file system. A program can be stored in a portion of a file that holds other programs and / or data (e.g., one or more scripts stored in a markup language document), in a single file dedicated to the program in question, and / or in multiple coordinated files (e.g., files that store one or more modules, sub programs, or portions of code). A computer program can be deployed to be executed on one computer or on multiple computers that may be located at one site or distributed across multiple sites and / or interconnected by a communication network.

[0103] The processes and / or logic flows described in this specification and / or in the accompanying figures may be performed by one or more programmable processors executing one or more computer programs to perform functions by operating on input data and / or generating output, thereby tying the process to a particular machine (e.g., a machine programmed to performAttorney Docket No. 926663-OO-WO-Ol-GD the processes described herein). The processes and / or logic flows can also be performed by, and apparatus can also be implemented as, special purpose logic circuitry, e.g., an FPGA (field programmable gate array) and / or an ASIC (application specific integrated circuit).

[0104] Computer readable media suitable for storing computer program instructions and / or data may include all forms of non-volatile memory, media and memory devices, including by way of example semiconductor memory devices (e.g., EPROM, EEPROM, and / or flash memory devices); magnetic disks (e.g., internal hard disks or removable disks); magneto optical disks; and / or CD ROM and DVD ROM disks. The processor and / or the memory can be supplemented by, or incorporated in, special purpose logic circuitry.

[0105] While this specification and the accompanying figures contain many specific implementation details, these should not be construed as limitations on the scope of any invention and / or of what may be claimed, but rather as descriptions of features that may be specific to described example implementations. Certain features that are described in this specification in the context of separate implementations can also be implemented in combination in perhaps one implementation. Various features that are described in the context of perhaps one implementation can also be implemented in multiple combinations separately or in any suitable sub-combination. Although features may be described above as acting in certain combinations and / or perhaps even (e.g., initially) claimed as such, one or more features from a claimed combination can in some cases be excised from the combination. The claimed combination may be directed to a subcombination and / or variation of a sub-combination.

[0106] While operations may be depicted in the drawings in an order, this should not be understood as requiring that such operations be performed in the particular order shown and / or in sequential order, and / or that all illustrated operations be performed, to achieve useful outcomes. The described program components and / or systems can generally be integrated together in a single software product and / or packaged into multiple software products.

[0107] Examples of the subject matter described in this specification have been described. The actions recited in the claims can be performed in a different order and still achieve useful outcomes, unless expressly noted otherwise. For example, the processes depicted in the accompanying figures do not require the particular order shown, and / or sequential order, to achieve useful outcomes. Multitasking and parallel processing may be advantageous in one or more scenarios.

[0108] While the present disclosure has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive inAttorney Docket No. 926663-OO-WO-Ol-GD character, it being understood that only certain examples have been shown and described, and that all changes and modifications that come within the spirit of the present disclosure are desired to be protected.

Claims

Attorney Docket No. 926663-OO-WO-Ol-GD CLAIMS WHAT IS CLAIMED IS:

1. An oral hygiene device, comprising:a dielectric barrier discharge (DBD) plasma source element configured to:be energized by an electrical power source; andgenerate plasma upon being energized;a mouthpiece tray configured with a cavity, the cavity configured to:receive the DBD plasma element;receive dentition of the device user;receive a treatment material; andbe placed into communication with the dentition of the device user, the device being configured such that the generated plasma advances a treatment corresponding to the treatment material of at least one of: the dentition of the device user, or an oral cavity tissue of the device user.

2. The device of claim 1, wherein the mouthpiece tray is further configured to:receive an application strip having at least a first side and a second side, the application strip configured to:receive the treatment material on the first side; andbe interposed in the mouthpiece cavity between the DBD plasma source element and the dentition of the device user.

3. The device of any of claim 1 or claim 2, wherein the mouthpiece tray is further configured to:comprise the DBD plasma element in at least one of: a fixed connection, or a removable connection.

4. The device of any of claim 2 to claim 3, wherein the mouthpiece tray is further configured to:comprise the application strip in at least one of: a fixed connection, or a removable connection.Attorney Docket No. 926663-OO-WO-Ol-GD 5. The device of any of claim 1 to claim 4, wherein the (DBD) plasma source element is a weave DBD plasma source element.

6. The device of any of claim 1 to claim 5, wherein the weave DBD plasma source element is configured to be flexibly adjustable in at least shape by a manual manipulation of the device user.

7. The device of any of claim 2 to claim 6, wherein the first side is configured to face a direction of the dentition of the device user and the second side is configured to face a direction of the DBD plasma source element.

8. The device of any of claim 1 to claim 7, wherein the device is further configured such that the treatment is at least one of: a whitening of the dentition of the device user, or a bacterial disinfection of the oral cavity tissue of the device user.

9. The device of any of claim 1 to claim 8, wherein the DBD plasma source element is comprised of fully insulated wires.

10. The device of any of claim 2 to claim 9, wherein the application strip is composed, at least in part, of Tyvek®.

11. The device of any of claim 1 to claim 10, wherein the treatment material is at least one of a whitening gel, or a hydrogen peroxide gel.

12. The device of any of claim 2 to claim 11, wherein the application strip is configured to insulate the oral cavity tissue of the device user from the generated plasma of the DBD plasma source element.

13. The device of any of claim 1 to claim 12, wherein the electrical power source is configured to produce an alternating current output in the range of 20 kHz to 100 kHz.

14. The device of any of claim 1 to claim 13, wherein the device is further configured to limit ozone produced by the generated plasma to less than 0.4 ppm for at least 60 seconds.Attorney Docket No. 926663-OO-WO-Ol-GD15. A method of applying an oral care treatment with an oral hygiene device, the method comprising:disposing a treatment material into a cavity of a mouthpiece tray, the cavity configured to receive at least one of: the treatment material, or a dielectric barrier discharge (DBD) plasma source element;placing the mouthpiece tray into communication with dentition of a device user; energizing the DBD plasma source element with an electrical power source; generating, by the DBD plasma source element, plasma upon the energizing of the DBD plasma device; andadvancing, by the generated plasma, a treatment corresponding to the treatment material of at least one of: the dentition of the device user, or an oral cavity tissue of the device user.

16. The method of claim 15, wherein the cavity is further configured to receive an application strip having at least a first side and a second side, the method further comprising:disposing the treatment material on the first side of the application strip; disposing the application strip into the cavity of the mouthpiece tray such that the second side faces a direction of the DBD plasma source element; andthe placing the mouthpiece tray into communication with the dentition of the device user further comprising interposing the application strip in the mouthpiece cavity between the DBD plasma source element and the dentition of the device user.

17. The method of any of claim 15 to claim 16, wherein the mouthpiece tray is further configured to:comprise the DBD plasma element in at least one of: a fixed connection, or a removable connection.

18. The method of any of claim 16 to claim 17, wherein the mouthpiece tray is further configured to:comprise the application strip in at least one of: a fixed connection, or a removableAttorney Docket No. 926663-OO-WO-Ol-GD connection.

19. The method of any of claim 15 to claim 18, wherein the (DBD) plasma source element is a weave DBD plasma source element.

20. The method of any of claim 15 to claim 19, further comprising flexibly adjusting at least a shape of the weave DBD plasma source element by a manual manipulation of the device user.

21. The method of any of claim 16 to claim 20, wherein the first side is configured to face a direction of the dentition of the device user and the second side is configured to face a direction of the DBD plasma source element.

22. The method of any of claim 15 to claim 21, wherein the device is further configured such that the treatment is at least one of: a whitening of the dentition of the device user, or a bacterial disinfection of the oral cavity tissue of the device user.

23. The method of any of claim 15 to claim 22, wherein the DBD plasma source element is comprised of fully insulated wires.

24. The method of any of claim 16 to claim 23, wherein the application strip is composed, at least in part, of Tyvek®.

25. The method of any of claim 15 to claim 24, wherein the treatment material is at least one of a whitening gel, or a hydrogen peroxide gel.

26. The method of any of claim 16 to claim 25, further comprising insulating, by the application strip, the oral cavity tissue of the device user from the generated plasma of the DBD plasma source element.

27. The method of any of claim 15 to claim 26, further comprising producing, by the electrical power source, an alternating current output in the range of 20 kHz to 100 kHz.Attorney Docket No. 926663-OO-WO-Ol-GD 28. The method of any of claim 15 to claim 27, further comprising limiting, by the device, ozone produced by the generated plasma to less than 0.4 ppm for at least 60 seconds.